Position in GUTS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$477
New position
Shares Held
1,042
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Avion Wealth holds $237,935 across 65 Biotechnology names. GUTS ranks #62 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $18,543 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
39 | $17,415 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
48 | $15,881 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
411 | $15,667 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
500 | $13,850 | |
| 6 | EXEL |
Exelixis, Inc.
|
260 | $11,151 | |
| 7 | MRNA |
Moderna, Inc.
|
189 | $9,601 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
153 | $9,593 |
All Filings in GUTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $477 | 1,042 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||